# MiNK Therapeutics, Inc.: Form DEF 14A, filed Apr 30, 2026

- Company: [MiNK Therapeutics, Inc.](/companies/inkt.md) (CIK 1840229)
- Form: DEF 14A
- Filed: 2026-04-30
- Accepted by EDGAR: Apr 30, 2026, 16:38 ET
- Period: 2026-06-17
- Accession: 0001193125-26-197577
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1840229/000119312526197577/mink-def_14a_2026.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1840229/000119312526197577/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1840229/000119312526197577/mink-def_14a_2026.htm

Filed Apr 30, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-197577. Last ingested by Listed: Nov 12, 2026, 21:09 ET. No prices; not investment advice.
